One World Products, Inc. (OWPC)

One World Products is a hemp and CBD producer focused on cultivation, processing, and ingredient supply. The company operates licensed hemp production and processing facilities in Colombia through its subsidiary One World Pharma SAS, selling hemp-derived raw materials — oils, distillates, isolates, and fiber — to manufacturers of pharmaceuticals, medical devices, consumer health products, and industrial applications. It trades on the OTCQB market under the ticker OWPC and is headquartered in Las Vegas, Nevada.

The business model

One World Products operates as a supply-side business in the hemp and CBD value chain. Rather than selling finished consumer products directly to end-users, the company grows and processes hemp, extracts cannabinoids (primarily CBD), and sells these raw materials in bulk to other manufacturers. A pharmaceutical company might buy OWPC’s CBD isolate to formulate a medical tincture. A consumer health brand might purchase crude hemp oil to include in topical creams or muscle rubs. An industrial company might buy hemp fiber for use in composites or textiles.

This model has advantages: it avoids the complexity of direct-to-consumer marketing, product liability associated with finished health claims, and the regulatory minefield of making medical assertions. The disadvantage is that it positions OWPC as a commodity supplier in a commoditizing market — unless the company can differentiate on quality, consistency, or cost, margins will compress as the market matures and new suppliers enter.

Geography and regulatory advantage

One World Pharma operates in Colombia, where hemp cultivation for industrial and pharmaceutical use is legal and regulated. This is a key strategic choice. Colombia has suitable climate and agricultural expertise, lower labour costs than North America, and a clear regulatory framework that allows large-scale hemp farming. The company holds licenses to cultivate hemp in the Cauca and Andina regions of Colombia (around Bogota and its surroundings), and was granted approval as one of the few legal sellers of characterized hemp seeds in those regions.

This geographic focus gives OWPC a potential cost advantage relative to North American producers, though it also creates supply-chain and political risk. Any disruption to Colombian operations — agricultural disease, political instability, or changes in Colombian hemp regulations — would immediately threaten the business.

From concept to extraction facility

The company has invested in infrastructure for both cultivation and processing. Early announcements indicated plans to build a vertically integrated, high-capacity extraction facility in Colombia, allowing OWPC to control both the growing and the conversion of raw plant material into refined ingredients. Vertical integration can improve margins and quality control but also ties up capital and creates operational complexity.

More recently, the company shifted strategy toward an asset-light model, reducing capital expenditure and overhead by divesting certain assets and focusing on higher-margin processing and ingredient sales. This suggests management is trying to improve profitability and flexibility, though it may also reflect capital constraints.

The market for hemp ingredients

The legitimate market for hemp-derived CBD is growing as medical and consumer uses expand. Physicians are studying CBD for chronic pain, anxiety, and seizure disorders. Consumer brands market CBD-infused oils, tinctures, topicals, and edibles. Industrial applications include textiles, composites, and bioplastics. None of this is hypothetical — these markets exist and are expanding in jurisdictions where hemp is legal.

However, the market is also increasingly crowded. Larger agricultural companies, established pharmaceutical firms, and well-capitalized startups have all moved into hemp production and CBD extraction. As supply increases and quality standards converge, prices and margins tend to fall. OWPC’s challenge is to maintain cost advantage and quality consistency while the market expands.

Products and customer engagement

One World Products has launched a consumer-facing product line as well. Pro-11 is a CBD-enriched muscle rub marketed to athletes and fitness enthusiasts for recovery and performance. This product serves partly as a proof-of-concept for what customers can do with OWPC’s ingredients and partly as a direct-revenue stream. However, finished consumer products face heavier regulatory scrutiny and marketing restrictions than raw ingredients, especially around health claims.

The company also positions itself as a supplier to automotive and packaging companies seeking sustainable, bio-based materials. This reflects a broader vision of hemp fiber and other hemp-derived compounds as replacements for plastics and traditional materials — a genuine long-term opportunity but one still in early stages.

Capital and execution

OWPC has attracted significant capital commitments from company insiders — the CEO and a director each invested $5 million personally into the company, signalling conviction in the strategy. This kind of insider investment is a positive signal about management’s confidence, though it doesn’t guarantee success.

The key metrics to watch are extraction efficiency (how much CBD extract you get from a given amount of raw plant), cost per kilogram of finished product, and the company’s ability to secure long-term supply contracts with major customers. If OWPC can lock in customers and demonstrate consistent, profitable ingredient production, the business model works. If it remains a small, struggling commodity producer, the stock will struggle.

How to research One World Products

Start with the 10-K and 10-Q filings (SEC CIK 0001622244). Look for:

• Revenue by product line. How much comes from bulk ingredient sales versus consumer products? Which is growing?
• Customer concentration. Does the company rely on a few large customers, or is the customer base diversified?
• Production capacity and utilization. Is the extraction facility running at full capacity? Are there constraints limiting growth?
• Gross margin trends. As the company scales, are margins improving or declining?

OWPC is a speculative investment in an emerging, growing market. The company operates in a legitimate but still-evolving industry, competes against larger players, and faces commodity pricing pressure. The upside depends on execution, customer relationships, and the continued expansion of legitimate hemp and CBD markets. The downside includes competition, regulatory changes, and the risk that the company’s assets prove inadequate to the scale of competition it faces.